XTL Biopharmaceuticals Ltd (H2K2) — Working Capital to Net Assets Ratio
XTL Biopharmaceuticals Ltd (H2K2) has a Working Capital to Net Assets ratio of -16.0% as of December 2024. Working capital of €-867.00K (current assets of €1.34 Million minus current liabilities of €2.21 Million) is measured against net assets of €5.43 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See H2K2 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
XTL Biopharmaceuticals Ltd Working Capital to Net Assets (2016–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of December 2024, the ratio stands at -16.0%, reflecting working capital of €-867.00K against net assets of €5.43 Million EUR. For the complete balance sheet picture, see XTL Biopharmaceuticals Ltd asset portfolio.
Annual Working Capital to Net Assets for XTL Biopharmaceuticals Ltd (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for XTL Biopharmaceuticals Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check H2K2 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -16.0% | €-867.00K | €5.43 Million | €1.34 Million | €2.21 Million | ▼ -98.8 pp |
| 2023 | 82.9% | €1.84 Million | €2.22 Million | €2.05 Million | €206.00K | ▼ -7.6 pp |
| 2022 | 90.5% | €3.62 Million | €4.00 Million | €3.81 Million | €187.00K | ▼ -22.1 pp |
| 2021 | 112.6% | €6.01 Million | €5.33 Million | €6.24 Million | €231.00K | ▲ +18.7 pp |
| 2020 | 93.9% | €5.87 Million | €6.25 Million | €6.12 Million | €254.00K | ▼ -0.6 pp |
| 2019 | 94.5% | €6.60 Million | €6.98 Million | €6.83 Million | €232.00K | ▼ -0.9 pp |
| 2018 | 95.4% | €7.94 Million | €8.32 Million | €8.20 Million | €253.00K | ▼ -67.8 pp |
| 2017 | 163.2% | €5.91 Million | €3.62 Million | €6.21 Million | €300.00K | ▲ +73.0 pp |
| 2016 | 90.2% | €2.42 Million | €2.69 Million | €2.75 Million | €330.00K | — |